What is Kromek Group plc?
Kromek Group plc, together with its subsidiaries, develops, manufactures, and sells radiation detection components and bio-detection technology solutions for the advanced imaging, CBRN detection, and biological threat detection markets.
KRMKF · Verdict
Moderate reward · elevated risk
KRMKF's standout is growth; valuation and cash flow weigh on the picture.
Based on 88% data coverage
KRMKF · Verdict
Rev +23.3% CAGR · earnings -15.0%
P/E 49.0×
-40% free-cash-flow margin
Current ratio 1.56
Model-based scoring. For information only — not financial advice.
Kromek Group plc, together with its subsidiaries, develops, manufactures, and sells radiation detection components and bio-detection technology solutions for the advanced imaging, CBRN detection, and biological threat detection markets. It offers civil nuclear radiation detection products, which include gamma radiation and neutron detectors, high-specification, high-resolution devices, components, and software for nuclear detection problems, as well as offers a range of radiation detectors that use cadmium zinc telluride (CZT) or scintillator technology for gamma-ray and neutron detection. The company is listed on the PINK in USA, operating in the Technology sector, with a market capitalisation of 101.02M, and a P/E ratio of 5.1x.
The scoring profile indicates limited reward potential at this time, with growth and momentum offering the most support. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.
For informational purposes only. Not financial advice.